Final Report: YrhB Fold Assignment and Functional Annotation — Imm35 Fold vs. Chaperone Activity

Executive Judgment

Verdict: Over-annotated (fold correct, function incorrect)

E. coli K12 YrhB (P46857) genuinely adopts the Imm35 structural fold (PF15567/IPR029082), confirmed by AlphaFold structure prediction (mean pLDDT = 95.2) and Foldseek structural homology searches (multiple hits with E-values < 10⁻¹⁰). However, the inferred molecular functions — bacteriocin immunity (GO:0030153) and peptidase inhibitor activity (GO:0030414) — are over-annotations unsupported by any experimental evidence in the entire Imm35 family. Direct experimental data from PMID: 22569261 demonstrates that YrhB functions as a chaperone-like protein with aggregation-prevention, ATP-independent refolding, and thermal-protection activities. The BL21(DE3) and K12 YrhB sequences are 100% identical, so these experimental results apply directly to K12. The ISS-based immunity annotations should not be assigned; instead, GO:0044183 (protein folding chaperone) is the best-supported molecular function term.

The most important caveats are: (1) the experimental chaperone data comes from a single study, albeit with multiple orthogonal assays; (2) it is formally possible that YrhB retains vestigial immunity-like binding capacity alongside its chaperone function; and (3) the Imm35 fold classification itself is based entirely on computational prediction without structural validation of any family member in complex with a cognate toxin. Notably, GO:0051082 (unfolded protein binding) — a term that might seem appropriate — is officially obsolete in the Gene Ontology, with GO:0044183 as its recommended replacement.

Summary

E. coli YrhB is a small (94-residue, 10.6 kDa) protein classified within the Imm35 / Immunity protein 35 family (InterPro IPR029082, Pfam PF15567). This family was computationally defined as part of the polymorphic toxin systems of bacteria, where immunity proteins neutralize cognate toxin domains. Based on this sequence-similarity classification, YrhB has been annotated — or proposed for annotation — with bacteriocin immunity (GO:0030153) and peptidase inhibitor activity (GO:0030414) by Inferred from Sequence Similarity (ISS). No experimental evidence supports these functional annotations.

Our three-iteration investigation confirms that YrhB adopts the Imm35 structural fold based on AlphaFold structure prediction and Foldseek searches. However, we find compelling evidence that the immunity/inhibitor annotations are over-annotations. First, a comprehensive survey of all 50 Imm35 family members in UniProt reveals that none have experimental evidence for immunity function — the entire family's functional assignment rests on genomic context (adjacency to toxin genes) and computational inference. Second, YrhB's genomic neighborhood in E. coli K12 lacks any adjacent toxin gene, undermining the contextual basis for the immunity prediction. Third, and most decisively, direct experimental work by Ahn et al. (2012) demonstrates that YrhB functions as a chaperone-like protein with multiple validated activities, using a protein 100% identical between the BL21(DE3) strain used in the study and the K12 reference strain.

We recommend that curators not assign GO:0030153 or GO:0030414 to YrhB, and instead annotate with GO:0044183 (protein folding chaperone) for molecular function and GO:0042026 (protein refolding) for biological process, supported by IDA (Inferred from Direct Assay) evidence from PMID: 22569261.

Key Findings

Finding 1: YrhB Has Experimentally Demonstrated Chaperone-Like Activity

The single most important piece of evidence in this investigation is the study by Ahn et al. (2012, PMID: 22569261), titled "YrhB is a highly stable small protein with unique chaperone-like activity in Escherichia coli BL21(DE3)." The authors directly characterized YrhB as a chaperone-like protein through multiple complementary assays:

1. Aggregation prevention: YrhB effectively prevented heat-induced aggregation of ribonucleotide synthetase (PurK), a classical holdase/chaperone assay.
2. ATP-independent refolding: Without ATP, YrhB alone promoted in vitro refolding of uridine phosphorylase (UDP), distinguishing it from ATP-dependent chaperone systems like GroEL/GroES.
3. Thermal protection: YrhB protected against thermal denaturation of refolded UDP, indicating sustained client stabilization.
4. Inclusion body reduction: As a cis-acting fusion partner, YrhB significantly reduced inclusion body formation of nine aggregation-prone heterologous proteins in BL21(DE3).
5. Essential at high temperature: YrhB was indispensable for growth of BL21(DE3) at 48°C, indicating a physiologically relevant role in thermal stress response.
6. Monomeric under stress: Unlike conventional small heat shock proteins (sHSPs), YrhB remained monomeric under heat shock conditions, suggesting a distinct mechanism.

Key abstract quote: "Escherichia coli YrhB (10.6 kDa) from strain BL21(DE3) that is commonly used for protein overexpression is a stable chaperone-like protein and indispensable for supporting the growth of BL21(DE3) at 48 °C but not defined as conventional heat shock protein (HSP). YrhB effectively prevented heat-induced aggregation of ribonucleotide synthetase (PurK). Without ATP, YrhB alone promoted in vitro refolding of uridine phosphorylase (UDP) and protected thermal denaturation of the refolded UDP."

This body of evidence — spanning in vitro biochemistry, in vivo functional assays, and phenotypic characterization — establishes chaperone-like activity as the primary experimentally validated function of YrhB.

Finding 2: Genomic Context Does Not Support Immunity Function

The Imm35 family was originally defined in the context of polymorphic toxin systems (PMID: 22731697), where immunity proteins are characteristically encoded immediately downstream of cognate toxin genes. Analysis of the E. coli K12 genomic neighborhood of yrhB (b3446) reveals:

• Upstream: IS1 insertion elements (insA-6/insB-6, b3444–b3445), a pseudogene yrhA (b3443), and the small uncharacterized yrhD (b4612).
• Downstream: γ-glutamyltranspeptidase ggt (b3447).

No protease, nuclease, or toxin gene (e.g., Tox-PL1, Ntox40, or any CdiA/Rhs-related toxin) is present in the immediate neighborhood. This absence of a cognate toxin gene is a critical negative finding, as the immunity function prediction for Imm35 proteins is fundamentally based on their genomic co-localization with toxin genes. The presence of IS elements and a pseudogene (yrhA) flanking yrhB is consistent with a scenario of evolutionary co-option: an ancestral toxin-immunity locus was disrupted by transposon insertion, the toxin was pseudogenized/lost, and the orphaned immunity protein was retained and repurposed for chaperone function.

Finding 3: No Imm35 Family Member Has Experimental Evidence for Immunity Function

A systematic survey of all 50 Imm35 (PF15567) proteins in UniProt revealed a striking finding: every single member is at protein existence level 3 (inferred from homology) or level 4 (predicted). None have experimental evidence at level 1 or 2. No GO annotations exist for any Imm35 family protein. The family name "Immunity protein 35" is itself entirely a computational prediction based on genomic context analysis from the polymorphic toxin system surveys.

Notably, some Imm35 entries occur as domains fused to Papain-fold toxin domains (e.g., A0A4R4ZA22 from Saccharopolyspora, A0A6G5RC39 from Streptomyces), which confirms the association of Imm35 domains with polymorphic toxin systems but does not demonstrate immunity function per se. A domain fused to a toxin could serve structural, regulatory, or chaperone-like roles rather than direct toxin neutralization.

This family-wide absence of experimental validation means that annotating any Imm35 member — including YrhB — with immunity-specific GO terms based solely on family membership represents a propagation of unverified computational predictions.

Finding 4: BL21(DE3) and K12 YrhB Are 100% Identical

A critical question was whether the chaperone data from the BL21(DE3) strain used by Ahn et al. could be directly applied to K12 YrhB. NCBI protein comparison confirmed that the two proteins are 100% identical across all 94 residues:

MITYHDAFAKANHYLDDADLPVVITLHGRFSQGWYFCFEAREFLETGDEAARLAGNAPFIIDKDSGEIHSLGTAKPLEEYLQDYEIKKATFGLP

Among five E. coli YrhB entries in UniProt, two are identical to K12 (QZI65628.1 from BL21(DE3) = WP_000634159.1/P46857 from K12) and three (from UPEC/ExPEC strains) show 95.7% identity with only four substitutions (H13N, D19N, I61V, D64G). This identity eliminates any concern about strain-specific differences and validates direct transfer of all experimental findings from PMID: 22569261 to K12 YrhB.

Finding 5: Current UniProt Entry Lacks GO Annotations

Examination of the current state of UniProt entry P46857 reveals an annotation score of 1.0, protein existence level 4 (predicted), and — importantly — no GO annotations at all. QuickGO returns zero hits for P46857 with GO:0030153 or GO:0030414. Furthermore, neither IPR029082 nor PF15567 have InterPro2GO or Pfam2GO mappings that would automatically generate these terms.

This means the ISS annotations referenced in the seed hypothesis cannot be confirmed in current public databases. The annotations may have been proposed but not applied, may exist in a specific database not surveyed, or may have been previously applied and subsequently removed. Regardless, this finding means the curation question is whether these terms should be assigned rather than whether existing assignments should be removed.

Finding 6: Correct GO Term for Chaperone Activity is GO:0044183

During annotation term selection, we identified that GO:0051082 (unfolded protein binding), which might seem appropriate for YrhB's client-binding activity, is obsolete in the Gene Ontology. The GO comment states: "The reason for obsoletion is that this binding term should be replaced by an activity term such as protein folding chaperone (GO:0044183) or unfolded protein holdase activity (GO:0140309)."

The correct primary MF term for YrhB is GO:0044183 (protein folding chaperone), defined as "Binding to a protein or protein-containing complex to assist the protein folding process." Since YrhB is ATP-independent, the child term GO:0140662 (ATP-dependent protein folding chaperone) does not apply. For biological process, GO:0042026 (protein refolding) is appropriate based on the in vitro refolding assay data.

Mechanistic Scope

Direct Gene-Product Activity

YrhB functions as a monomeric, ATP-independent chaperone-like protein that binds unfolded or partially folded protein clients to:

1. Prevent aggregation (holdase activity) — demonstrated with PurK as substrate
2. Promote refolding (foldase-like activity) — demonstrated with uridine phosphorylase
3. Stabilize folded state — protects refolded UDP from thermal denaturation

The mechanism is distinct from conventional small heat shock proteins (sHSPs, e.g., IbpA/IbpB) in that YrhB remains monomeric under heat shock rather than forming oligomeric complexes. This suggests a different client-interaction mode, possibly involving the surface features of the Imm35 fold. The α+β architecture with a conserved Trp34 may provide hydrophobic patches suitable for client recognition.

Separation from Downstream Phenotypes

The following observations are downstream phenotypes rather than direct molecular functions and should be annotated with IMP (Inferred from Mutant Phenotype) if used:

• Essential for growth at 48°C: This is a loss-of-function phenotype indicating physiological importance but not directly defining molecular function.
• Reduction of inclusion body formation: This in vivo outcome likely reflects the aggregate-prevention activity but could involve additional cellular factors.
• Enhancement of heterologous protein solubility as fusion partner: This is a biotechnological application consequence of the chaperone activity.

Relationship Between Fold and Function

A key insight from this investigation is that structural fold does not deterministically predict function. YrhB adopts the Imm35 fold yet performs chaperone activity rather than toxin neutralization. This is not unprecedented — the PepSY domain from Bacillus megaterium YpeB (PMID: 26219275) was named for predicted peptidase inhibitory function but actually serves a structural/stabilization role in spore germination, providing a direct precedent for fold-function dissociation. The Imm35 fold may have originated in polymorphic toxin systems but has been co-opted for chaperone function in E. coli K12 YrhB.

Evidence Matrix

GO Curation Implications

Current State

• P46857 (YrhB) has NO GO annotations in UniProt, QuickGO, or AmiGO
• The ISS annotations referenced in the seed hypothesis (GO:0030153, GO:0030414) cannot be confirmed in current public databases
• InterPro/Pfam Imm35 family has no GO term mappings (InterPro2GO/Pfam2GO: None)

Recommended Curation Actions (Leads for Curator Verification)

1. DO NOT assign GO:0030153 (bacteriocin immunity) or GO:0030414 (peptidase inhibitor activity)

These terms lack any experimental support for YrhB or any other Imm35 family member. The Imm35 fold classification does not constitute evidence for these specific functions. Assigning them by ISS would propagate unvalidated computational predictions.

2. Assign GO:0044183 (protein folding chaperone) — Molecular Function

• Evidence code: IDA (Inferred from Direct Assay)
• Reference: PMID: 22569261
• Justification: Multiple assays demonstrate aggregation prevention, refolding promotion, and thermal protection — all hallmarks of chaperone activity. The protein is ATP-independent, so the parent term GO:0044183 is appropriate rather than the ATP-dependent child term GO:0140662.
• Important: GO:0051082 (unfolded protein binding) is OBSOLETE and must NOT be used. The GO Consortium recommends GO:0044183 as its replacement.

3. Assign GO:0042026 (protein refolding) — Biological Process

• Evidence code: IDA
• Reference: PMID: 22569261
• Justification: YrhB promotes in vitro refolding of uridine phosphorylase without ATP.

4. Consider GO:0006457 (protein folding) — Biological Process

• Evidence code: IMP (Inferred from Mutant Phenotype)
• Reference: PMID: 22569261
• Justification: YrhB is indispensable for growth at 48°C and reduces inclusion body formation in vivo, consistent with a physiological role in protein folding under stress.

5. Consider GO:0034605 (cellular response to heat) — Biological Process

• Evidence code: IMP
• Reference: PMID: 22569261
• Justification: Indispensable for growth at 48°C.

6. Consider GO:0005737 (cytoplasm) — Cellular Component

• Evidence code: IDA or IEA
• Justification: YrhB lacks a signal peptide; is a soluble cytoplasmic protein based on overexpression studies.

GO Decision Summary Table

Conflicts and Alternatives

Conflict 1: Domain Family Name vs. Experimental Function

The Imm35 domain family (PF15567/IPR029082) is described as a "predicted immunity protein" based on genomic context — it is found adjacent to protease/toxin genes in other bacteria. However, this function is computational prediction only — no Imm35 protein has been experimentally shown to have immunity function. YrhB is the only reviewed UniProt protein in the family, and its experimentally demonstrated function (chaperone) contradicts the family name. The defining genomic context (adjacent toxin gene) is absent in E. coli K12.

Conflict 2: NCBI vs. UniProt vs. InterPro Annotation

Different databases provide contradictory functional interpretations: - NCBI Gene: describes yrhB as "putative heat shock chaperone" (informed by 22569261) - UniProt: names it "Uncharacterized protein YrhB" (no curation of experimental paper) - InterPro/Pfam: classifies it as "Immunity protein 35" (domain family name)

This discrepancy creates confusion for automated annotation pipelines and downstream users.

Alternative Interpretation: Evolutionary Co-option

The most parsimonious interpretation reconciling the structural fold with the experimental function is evolutionary co-option:

1. An ancestral Imm35 immunity protein was acquired (possibly by horizontal transfer — IS elements flank the region)
2. The cognate toxin gene was lost (yrhA is now a pseudogene)
3. The orphaned Imm35 protein was retained and co-opted for chaperone function
4. The α+β fold with exposed hydrophobic surfaces may have pre-adapted the protein for chaperone activity

This interpretation reconciles the structural fold assignment (Imm35 = correct) with the functional evidence (chaperone = experimentally supported). The IS elements flanking the locus and the adjacent pseudogene are consistent with a disrupted ancestral toxin-immunity pair.

Alternative Interpretation: Dual/Moonlighting Function

It remains formally possible that YrhB could have both chaperone activity and residual immunity-like binding capacity. Some proteins are known to moonlight with different functions in different contexts. However, there is no evidence for immunity function, and the absence of a cognate toxin gene in K12 means there is no selective pressure to maintain immunity function.

Paralog Confusion Assessment

No paralogs of yrhB exist in E. coli K12. Orthologs in other Enterobacteriaceae are annotated as "Immunity protein 35 domain-containing protein" — it is unknown whether these orthologs retain immunity function or have also adopted chaperone activity. YrhB is not easily confused with well-characterized colicin immunity proteins (Im7, Im9, Cmi), which belong to entirely different structural families.

Knowledge Gaps

Discriminating Tests

High Priority

1. Toxin neutralization assay: Express YrhB with known polymorphic toxin domains (especially any toxin computationally predicted to pair with Imm35) and test for neutralization in vivo and in vitro. A negative result would definitively refute immunity function.

2. Structural determination of YrhB–client complex: Solve the crystal structure of YrhB bound to an unfolded client protein to identify the binding surface and mechanism. Compare to predicted toxin-binding interfaces.

3. Interactome mapping: Use crosslinking mass spectrometry or co-immunoprecipitation under heat stress to identify YrhB's in vivo protein clients in K12. If clients are general unfolded proteins rather than specific toxins, this supports chaperone function.

Medium Priority

1. K12 deletion phenotype: Construct a clean ΔyrhB strain in K12 MG1655 and test growth at 37°C, 42°C, and 48°C. While the Ahn study used BL21(DE3), confirming the phenotype in K12 would strengthen the annotation.

2. Transcriptomic analysis: Determine whether yrhB is induced by heat shock, envelope stress, or other protein-misfolding conditions using qRT-PCR or RNA-seq.

3. Surface conservation mapping: Map sequence conservation across Imm35 family members onto the AlphaFold structure to identify conserved surface patches (functional binding site).

Lower Priority

1. Heterologous immunity complementation: Express YrhB in a strain susceptible to a toxin associated with Imm35 domains in other organisms. Negative protection further weakens the immunity hypothesis.

2. Holdase vs. foldase dissection: Systematic mutagenesis to separate aggregation-prevention from refolding-promotion activities.

Curation Leads

Lead 1: Remove/Do Not Assign ISS Immunity Annotations

• Action: Do NOT assign GO:0030153 or GO:0030414 to P46857
• Basis: Experimental evidence (22569261) demonstrates chaperone function; genomic context lacks toxin partner; entire Imm35 family function is unvalidated computational prediction
• Confidence: HIGH

Lead 2: Add Chaperone Function Annotations

• Candidate terms: GO:0044183 (protein folding chaperone, MF — primary), GO:0042026 (protein refolding, BP)
• Evidence code: IDA based on PMID: 22569261
• Reference snippet to verify: "Escherichia coli YrhB (10.6 kDa) from strain BL21(DE3) that is commonly used for protein overexpression is a stable chaperone-like protein and indispensable for supporting the growth of BL21(DE3) at 48 °C but not defined as conventional heat shock protein (HSP). YrhB effectively prevented heat-induced aggregation of ribonucleotide synthetase (PurK). Without ATP, YrhB alone promoted in vitro refolding of uridine phosphorylase (UDP) and protected thermal denaturation of the refolded UDP."
• Strain note: BL21(DE3) and K12 YrhB are 100% identical — results directly applicable

Lead 3: Obsolete Term Warning

• Action: Do NOT use GO:0051082 (unfolded protein binding) — it is obsolete
• Replacement: GO:0044183 (protein folding chaperone) per GO Consortium recommendation

Lead 4: Update UniProt Entry

• Update protein existence from level 4 to level 1 (evidence at protein level)
• Update name from "Uncharacterized protein YrhB" to reflect chaperone activity
• Add function comment referencing 22569261

Lead 5: Imm35 Family-Level Consideration

• No Imm35 (PF15567) protein has experimentally confirmed immunity function
• YrhB is the only reviewed/experimentally characterized member
• Consider whether InterPro/Pfam family description should note this and mention the experimentally demonstrated chaperone function
• The family name "Immunity protein 35" may be misleading for downstream annotation pipelines

Lead 6: If ISS Annotations Were Previously Curated

• If GO:0030153 and GO:0030414 were previously assigned by ISS and subsequently removed, the removal was justified
• If they still exist in a non-public or curator-internal database, they should be removed with 22569261 as basis for replacement with chaperone terms

Methodological Notes

Databases and Tools Used

• UniProt / QuickGO / AmiGO: GO annotation status for P46857 and all PF15567 members
• NCBI Protein: Sequence comparison between BL21(DE3) and K12 YrhB
• Ensembl Bacteria: Genomic neighborhood analysis of b3446
• AlphaFold: Structure prediction for P46857 (AF-P46857-F1-v6)
• Foldseek: Structural homology search against AFDB50 and PDB100
• PubMed: Literature searches for "yrhB", "Imm35", "PF15567", "polymorphic toxin immunity", "small chaperone E. coli"
• Gene Ontology: Term definitions, obsolescence status, and term relationships

Literature Coverage

• 13 papers reviewed across three iterations
• 1 paper with direct YrhB experimental data (PMID: 22569261)
• Multiple papers on polymorphic toxin systems, colicin immunity proteins, and related structural biology providing contextual framework